Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMS Buys Influence, Inc. To Expand Incontinence Product Offerings

This article was originally published in The Gray Sheet

Executive Summary

American Medical Systems is bulking up its sales force and expanding its urology product offerings through its planned acquisition of Influence, Inc. Terms of a Nov. 29 definitive merger agreement were not disclosed.

You may also be interested in...



Erectile Dysfunction Device Business May Benefit From Viagra Alternatives

American Medical Systems attributes its 48% annual growth rate in female incontinence revenue to a swift succession of 510(k) product clearances

Erectile Dysfunction Device Business May Benefit From Viagra Alternatives

American Medical Systems attributes its 48% annual growth rate in female incontinence revenue to a swift succession of 510(k) product clearances

AMS' Planned IPO Proceeds To Pay Down Debt, Complete Influence Payments

A planned initial public offering by American Medical Systems Holdings, Inc., maker of urological disorder treatment devices, is anticipated to raise $68.8 mil. -including $40 mil. tabbed to "repay all of the outstanding debt under the guaranteed portion" of a $115 mil. credit facility.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012660

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel